Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.61 USD | -1.08% | +26.01% | +72.18% |
12:52pm | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.18% | 641M | |
+16.90% | 121B | |
+13.16% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.17% | 15.31B | |
+1.16% | 14.08B | |
+24.02% | 11.74B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Mizuho Trims Price Target on Selecta Biosciences to $3 From $4, Maintains Buy Rating